Mark For: LENHELIO™ trademark registration is intended to cover the categories of
Website | www.gilead.com |
Research | OneLook Acronym Finder |
Serial Number | 97595391 |
Mark Literal Elements | LENHELIO |
Mark Drawing Type | 4 - STANDARD CHARACTER MARK |
Mark Type | Trademark |
Current Location | NEW APPLICATION PROCESSING 2022-09-20 |
Basis | 1(b) 44(d) |
Class Status | ACTIVE |
Primary US Classes |
|
Primary International Class |
|
Filed Use | No |
Current Use | No |
Intent To Use | Yes |
Filed ITU | Yes |
44D Filed | Yes |
44E Current | No |
66A Current | No |
Current Basis | No |
No Basis | No |
Attorney Name | Jack Wessel |
Attorney Docket Number | 13039-US-NF |
2022-09-16 | Application Filed |
2022-09-20 | Location: NEW APPLICATION PROCESSING |
2022-09-20 | Status: Live/Pending |
2022-09-20 | Status: New application awaiting assignment to an examining attorney. See current trademark processing wait times for more information. |
2022-09-20 | Transaction Date |
Party: | Gilead Sciences Ireland UC |
Address | IDA Business & Technology Park Carrigtohill, Co. Cork IRELAND |
Legal Entity Type | Unlimited Company |
Legal Entity State | IRELAND |
Application | 2022-09-16 | |
Drawing | 2022-09-16 |
International Codes: | 5 |
U.S. Codes: | 005,006,018,044,046,051,052 |
Type Code | Type |
---|---|
GS0051 | Antiviral pharmaceutical preparations; anti-infective pharmaceutical preparations; anti-fibrotic pharmaceutical preparations; pharmaceutical preparations for treatment and prevention of HIV infection; pharmaceutical preparations for the treatment of liver diseases and disorders; pharmaceutical preparations for the treatment of hematological diseases and disorders; pharmaceutical preparations for the treatment of oncological diseases and disorders; pharmaceutical preparations for the treatment of inflammatory diseases and disorders; pharmaceutical preparations for the treatment of autoimmune diseases and disorders; pharmaceutical preparations for the treatment of respiratory and pulmonary diseases and disorders; pharmaceutical preparations for the treatment of kidney and nephropathic diseases and disorders; pharmaceutical preparations for the treatment of arthritis; pharmaceutical preparations for treatment of gastrointestinal diseases and disorders |
Description | Date | Proceeding Number |
---|---|---|
NEW APPLICATION ENTERED IN TRAM | 2022-09-20 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.